Xiaozhong Wang

2.1k citations
59 papers · 1.3k indexed · h-index 16
Topics
Ferroptosis and cancer prognosis (12 papers)Cancer-related molecular mechanisms research (8 papers)Cancer Immunotherapy and Biomarkers (6 papers)

In The Last Decade

Xiaozhong Wang

57 papers receiving 1.3k citations

Peers

Xiaozhong Wang
Comparison fields: 5 of 111
  • Molecular Biology 693
  • Cancer Research 411
  • Oncology 238
  • Immunology 168
  • Surgery 134
Replace Hsien‐Bin Huang with:
Hsien‐Bin Huang Taiwan
Chao Tang China
Lea Madi Israel
Juan Wu China
Lida Guo United States
Shan Yan United States
Caiguo Zhang United States
Amar Bennasroune France
Yongwei Zhang United States
Xiaozhong Wang relative to Hsien‐Bin Huang Taiwan Hsien‐Bin Huang's profile →
Citations per field
00.5×4.3×
Hsien‐Bin Huang · 1×
Citations per year

Countries citing papers authored by Xiaozhong Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaozhong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaozhong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaozhong Wang more than expected).

Fields of papers citing papers by Xiaozhong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaozhong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaozhong Wang. The network helps show where Xiaozhong Wang may publish in the future.

Co-authorship network of co-authors of Xiaozhong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaozhong Wang. A scholar is included among the top collaborators of Xiaozhong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaozhong Wang. Xiaozhong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 2
5 3
6 3
7 12
8 2
9 6
10 1
11 3
12 1
13 3
14 15
15 14
16 5
17 21
18 2
19 25
20 13

About Xiaozhong Wang

Xiaozhong Wang is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 59 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (12 papers), Cancer-related molecular mechanisms research (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Cancer Research (411 citations), Molecular Biology (693 citations) and Oncology (238 citations). Xiaozhong Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Hong Hua Su, Melanie I. Trombly, Jian Chen, Joshua R. Sanes, Juan Carlos Tapia, Joshua A. Weiner, Kaili Liao, Jean Buteau, Gary J. Kociba and Dan Lü. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026